Goldman Sachs analyst Brian Lee maintains Maxeon Solar Technologies (NASDAQ:MAXN) with a Sell and raises the price target from $8 to $9.
SVB Leerink Maintains Outperform on Gossamer Bio, Lowers Price Target to $10
SVB Leerink analyst Joseph Schwartz maintains Gossamer Bio (NASDAQ:GOSS) with a Outperform and lowers the price target from $15 to $10.